Whole chromosome aneuploidy: Big mutations drive adaptation by phenotypic leap

BioEssays

Volumn 34, Issue 10, 2012, Pages 893-900

  Chen, Guangbo ^a,b   Rubinstein, Boris ^a   Li, Rong ^a,b  

^a STOWERS INSTITUTE FOR MEDICAL RESEARCH   (United States)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

Adaptation; Aneuploidy; Population; Stress

Indexed keywords

ANEUPLOIDY; ANGIOGENESIS; ARTICLE; CANDIDA ALBICANS; CARCINOGENESIS; CELL PROLIFERATION; CHROMOSOMAL INSTABILITY; COPY NUMBER VARIATION; CRYPTOCOCCUS NEOFORMANS; DOWN SYNDROME; ENVIRONMENTAL STRESS; EVOLUTIONARY ADAPTATION; GENE DELETION; GENE MUTATION; GENETIC VARIABILITY; HUMAN; KARYOTYPE; LEISHMANIA; MYELOPROLIFERATIVE DISORDER; NONHUMAN; PHENOTYPE; SACCHAROMYCES CEREVISIAE; STRESS; WELLBEING;

ABNORMAL KARYOTYPE; ADAPTATION, BIOLOGICAL; ANEUPLOIDY; ANIMALS; CHROMOSOMAL INSTABILITY; CHROMOSOMES; EVOLUTION, MOLECULAR; HUMANS; MUTAGENESIS; PHENOTYPE;

EID: 84866296846     PISSN: 02659247     EISSN: 15211878     Source Type: Journal    
DOI: 10.1002/bies.201200069     Document Type: Article

References (74)

1. Walczak CE, Cai S, Khodjakov A. 2010. Mechanisms of chromosome behaviour during mitosis. Nat Rev Mol Cell Biol 11: 91- 102.
2. Kitagawa K, Hieter P. 2001. Evolutionary conservation between budding yeast and human kinetochores. Nat Rev Mol Cell Biol 2: 678- 87.
3. Maresca TJ, Salmon ED. 2010. Welcome to a new kind of tension: translating kinetochore mechanics into a wait-anaphase signal. J Cell Sci 123: 825- 35.
4. Lew DJ, Burke DJ. 2003. The spindle assembly and spindle position checkpoints. Annu Rev Genet 37: 251- 82.
5. Selmecki A, Forche A, Berman J. 2010. Genomic plasticity of the human fungal pathogen Candida albicans. Eukaryot Cell 9: 991- 1008.
6. Pavelka N, Rancati G, Li R. 2010. Dr Jekyll and Mr Hyde: role of aneuploidy in cellular adaptation and cancer. Curr Opin Cell Biol 22: 809- 15.
7. Gordon DJ, Resio B, Pellman D. 2012. Causes and consequences of aneuploidy in cancer. Nat Rev Genet 13: 189- 203.
8. Sheltzer JM, Amon A. 2011. The aneuploidy paradox: costs and benefits of an incorrect karyotype. Trends Genet 27: 446- 53.
9. Patterson D, Costa ACS. 2005. Down syndrome and genetics - a case of linked histories. Nat Rev Genet 6: 137- 47.
10. Holland AJ, Cleveland DW. 2009. Boveri revisited: chromosomal instability, aneuploidy and tumorigenesis. Nat Rev Mol Cell Biol 10: 478- 87.
11. Kingsbury MA, Yung YC, Peterson SE, Westra JW, et al. 2006. Aneuploidy in the normal and diseased brain. Cell Mol Life Sci 63: 2626- 41.
12. Duncan AW, Taylor MH, Hickey RD, Hanlon Newell AE, et al. 2010. The ploidy conveyor of mature hepatocytes as a source of genetic variation. Nature 467: 707- 10.
13. Duncan AW, Hanlon Newell AE, Smith L, Wilson EM, et al. 2012. Frequent aneuploidy among normal human hepatocytes. Gastroenterology 142: 25- 8.
14. Hughes TR, Roberts CJ, Dai H, Jones AR, et al. 2000. Widespread aneuploidy revealed by DNA microarray expression profiling. Nat Genet 25: 333- 7.
15. Kvitek DJ, Will JL, Gasch AP. 2008. Variations in stress sensitivity and genomic expression in diverse S. cerevisiae isolates. PLoS Genet 4: e1000223.
16. Codon AC, Benitez T, Korhola M. 1998. Chromosomal polymorphism and adaptation to specific industrial environments of Saccharomyces strains. Appl Microbiol Biotechnol 49: 154- 63.
17. Bond U, Neal C, Donnelly D, James T. 2004. Aneuploidy and copy number breakpoints in the genome of lager yeasts mapped by microarray hybridisation. Curr Genet 45: 360- 70.
18. Borneman AR, Desany BA, Riches D, Affourtit JP, et al. 2011. Whole-genome comparison reveals novel genetic elements that characterize the genome of industrial strains of Saccharomyces cerevisiae. PLoS Genet 7: e1001287.
19. Infante JJ, Dombek KM, Rebordinos L, Cantoral JM, et al. 2003. Genome-wide amplifications caused by chromosomal rearrangements play a major role in the adaptive evolution of natural yeast. Genetics 165: 1745- 59.
20. Hu G, Liu I, Sham A, Stajich JE, et al. 2008. Comparative hybridization reveals extensive genome variation in the AIDS-associated pathogen Cryptococcus neoformans. Genome Biol 9: R41.
21. Selmecki A, Forche A, Berman J. 2006. Aneuploidy and isochromosome formation in drug-resistant Candida albicans. Science 313: 367- 70.
22. Sionov E, Lee H, Chang YC, Kwon-Chung KJ. 2010. Cryptococcus neoformans overcomes stress of azole drugs by formation of disomy in specific multiple chromosomes. PLoS Pathog 6: e1000848.
23. Murray HW, Berman JD, Davies CR, Saravia NG. 2005. Advances in leishmaniasis. Lancet 366: 1561- 77.
24. Rogers MB, Hilley JD, Dickens NJ, Wilkes J, et al. 2011. Chromosome and gene copy number variation allow major structural change between species and strains of Leishmania. Genome Res 21: 2129- 42.
25. Akopyants NS, Kimblin N, Secundino N, Patrick R, et al. 2009. Demonstration of genetic exchange during cyclical development of Leishmania in the sand fly vector. Science 324: 265- 8.
26. Vanneste E, Voet T, Le Caignec C, Ampe M, et al. 2009. Chromosome instability is common in human cleavage-stage embryos. Nat Med 15: 577- 83.
27. van Echten-Arends J, Mastenbroek S, Sikkema-Raddatz B, Korevaar JC, et al. 2011. Chromosomal mosaicism in human preimplantation embryos: a systematic review. Hum Reprod Update 17: 620- 7.
28. Weaver BAA, Cleveland DW. 2006. Does aneuploidy cause cancer? Curr Opin Cell Biol 18: 658- 67.
29. Ozery-Flato M, Linhart C, Trakhtenbrot L, Izraeli S, et al. 2011. Large-scale analysis of chromosomal aberrations in cancer karyotypes reveals two distinct paths to aneuploidy. Genome Biol 12: R61.
30. Yurov YB, Iourov IY, Vorsanova SG, Liehr T, et al. 2007. Aneuploidy and confined chromosomal mosaicism in the developing human brain. PLoS One 2: e558.
31. Rehen SK, Yung YC, McCreight MP, Kaushal D, et al. 2005. Constitutional aneuploidy in the normal human brain. J Neurosci 25: 2176- 80.
32. Henry IM, Dilkes BP, Miller ES, Burkart-Waco D, et al. 2010. Phenotypic consequences of aneuploidy in Arabidopsis thaliana. Genetics 186: 1231- 45.
33. Huettel B, Kreil DP, Matzke M, Matzke AJ. 2008. Effects of aneuploidy on genome structure, expression, and interphase organization in Arabidopsis thaliana. PLoS Genet 4: e1000226.
34. Pavelka N, Rancati G, Zhu J, Bradford WD, et al. 2010. Aneuploidy confers quantitative proteome changes and phenotypic variation in budding yeast. Nature 468: 321- 5.
35. Selmecki A, Gerami-Nejad M, Paulson C, Forche A, et al. 2008. An isochromosome confers drug resistance in vivo by amplification of two genes, ERG11 and TAC1. Mol Microbiol 68: 624- 41.
36. Torres EM, Sokolsky T, Tucker CM, Chan LY, et al. 2007. Effects of aneuploidy on cellular physiology and cell division in haploid yeast. Science 317: 916- 24.
37. Rancati G, Pavelka N, Fleharty B, Noll A, et al. 2008. Aneuploidy underlies rapid adaptive evolution of yeast cells deprived of a conserved cytokinesis motor. Cell 135: 879- 93.
38. Gao C, Furge K, Koeman J, Dykema K, et al. 2007. Chromosome instability, chromosome transcriptome, and clonal evolution of tumor cell populations. Proc Natl Acad Sci USA 104: 8995- 9000.
39. Williams BR, Prabhu VR, Hunter KE, Glazier CM, et al. 2008. Aneuploidy affects proliferation and spontaneous immortalization in mammalian cells. Science 322: 703- 9.
40. Upender MB, Habermann JK, McShane LM, Korn EL, et al. 2004. Chromosome transfer induced aneuploidy results in complex dysregulation of the cellular transcriptome in immortalized and cancer cells. Cancer Res 64: 6941- 9.
41. Torres EM, Dephoure N, Panneerselvam A, Tucker CM, et al. 2010. Identification of aneuploidy-tolerating mutations. Cell 143: 71- 83.
42. Chen G, Bradford WD, Seidel CW, Li R. 2012. Hsp90 stress potentiates rapid cellular adaptation through induction of aneuploidy. Nature 482: 246- 50.
43. Tolliday N, Pitcher M, Li R. 2003. Direct evidence for a critical role of myosin II in budding yeast cytokinesis and the evolvability of new cytokinetic mechanisms in the absence of myosin II. Mol Biol Cell 14: 798- 809.
44. Sheltzer JM, Blank HM, Pfau SJ, Tange Y, et al. 2011. Aneuploidy drives genomic instability in yeast. Science 333: 1026- 30.
45. Eyre-Walker A, Keightley PD. 2007. The distribution of fitness effects of new mutations. Nat Rev Genet 8: 610- 8.
46. Geiger T, Cox J, Mann M. 2010. Proteomic changes resulting from gene copy number variations in cancer cells. PLoS Genet 6: e1001090.
47. Hanahan D, Weinberg RA. 2000. The hallmarks of cancer. Cell 100: 57- 70.
48. Roper RJ, Reeves RH. 2006. Understanding the basis for Down syndrome phenotypes. PLoS Genet 2: e50.
49. Merlo LMF, Pepper JW, Reid BJ, Maley CC. 2006. Cancer as an evolutionary and ecological process. Nat Rev Cancer 6: 924- 35.
50. Heng HH, Bremer SW, Stevens JB. Ye KJ, et al. 2009. Genetic and epigenetic heterogeneity in cancer: a genome-centric perspective. J Cell Physiol 220: 538- 47.
51. Grimwade D, Walker H, Oliver F, Wheatley K, et al. 1998. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1, 612 patients entered into the MRC AML 10 trial. Blood 92: 2322- 33.
52. Le Beau MM, Bitts S, Davis EM, Kogan SC. 2002. Recurring chromosomal abnormalities in leukemia in PML-RARA transgenic mice parallel human acute promyelocytic leukemia. Blood 99: 2985- 91.
53. Jones L, Wei G, Sevcikova S, Phan V, et al. 2010. Gain of MYC underlies recurrent trisomy of the MYC chromosome in acute promyelocytic leukemia. J Exp Med 207: 2581- 94.
54. Hasle H, Clemmensen IH, Mikkelsen M. 2000. Risks of leukaemia and solid tumours in individuals with Down's syndrome. Lancet 355: 165- 9.
55. Yang Q, Rasmussen SA, Friedman JM. 2002. Mortality associated with Down's syndrome in the USA from 1983 to 1997: a population-based study. Lancet 359: 1019- 25.
56. Zipursky A, Brown EJ, Christensen H, Doyle J. 1999. Transient myeloproliferative disorder (transient leukemia) and hematologic manifestations of Down syndrome. Clin Lab Med 19: 157- 67 vii.
57. Kirsammer G, Jilani S, Liu H, Davis E, et al. 2008. Highly penetrant myeloproliferative disease in the Ts65Dn mouse model of Down syndrome. Blood 111: 767- 75.
58. Ng AP, Hyland CD, Metcalf D, Carmichael CL, et al. 2010. Trisomy of Erg is required for myeloproliferation in a mouse model of Down syndrome. Blood 115: 3966- 9.
59. Navin N, Kendall J, Troge J, Andrews P, et al. 2011. Tumour evolution inferred by single-cell sequencing. Nature 472: 90- 4.
60. Esposito MS, Maleas DT, Bjornstad KA, Bruschi CV. 1982. Simultaneous detection of changes in chromosome number, gene conversion and intergenic recombination during mitosis of Saccharomyces cerevisiae: spontaneous and ultraviolet light induced events. Curr Genet 6: 5- 11.
61. Lang GI, Murray AW. 2008. Estimating the per-base-pair mutation rate in the yeast Saccharomyces cerevisiae. Genetics 178: 67- 82.
62. Lynch M, Sung W, Morris K, Coffey N, et al. 2008. A genome-wide view of the spectrum of spontaneous mutations in yeast. Proc Natl Acad Sci USA 105: 9272- 7.
63. Sotillo R, Hernando E, Díaz-Rodríguez E, Teruya-Feldstein J, et al. 2007. Mad2 overexpression promotes aneuploidy and tumorigenesis in mice. Cancer Cell 11: 9- 23.
64. Hanks S, Coleman K, Reid S, Plaja A, et al. 2004. Constitutional aneuploidy and cancer predisposition caused by biallelic mutations in BUB1B. Nat Genet 36: 1159- 61.
65. Snape K, Hanks S, Ruark E, Barros-Núñez P, et al. 2011. Mutations in CEP57 cause mosaic variegated aneuploidy syndrome. Nat Genet 43: 527- 9.
66. Weaver BAA, Silk AD, Montagna C, Verdier-Pinard P, et al. 2007. Aneuploidy acts both oncogenically and as a tumor suppressor. Cancer Cell 11: 25- 36.
67. Putkey FR, Cramer T, Morphew MK, Silk AD, et al. 2002. Unstable kinetochore-microtubule capture and chromosomal instability following deletion of CENP-E. Dev Cell 3: 351- 65.
68. Stemmann O, Neidig A, Köcher T, Wilm M, et al. 2002. Hsp90 enables Ctf13p/Skp1p to nucleate the budding yeast kinetochore. Proc Natl Acad Sci USA 99: 8585- 90.
69. Rodrigo-Brenni MC, Thomas S, Bouck DC, Kaplan KB. 2004. Sgt1p and Skp1p modulate the assembly and turnover of CBF3 complexes required for proper kinetochore function. Mol Biol Cell 15: 3366- 78.
70. Forche A, Abbey D, Pisithkul T, Weinzierl MA, et al. 2011. Stress alters rates and types of loss of heterozygosity in Candida albicans. MBio 2: pii: e00129-11.
71. Whitesell L, Lindquist SL. 2005. HSP90 and the chaperoning of cancer. Nat Rev Cancer 5: 761- 72.
72. Tang YC, Williams BR, Siegel JJ, Amon A. 2011. Identification of aneuploidy-selective antiproliferation compounds. Cell 144: 499- 512.
73. Davies AE, Kaplan KB. 2010. Hsp90-Sgt1 and Skp1 target human Mis12 complexes to ensure efficient formation of kinetochore-microtubule binding sites. J Cell Biol 189: 261- 74.
74. Niikura Y, Ohta S, Vandenbeldt KJ, Abdulle R, et al. 2006. 17-AAG, an Hsp90 inhibitor, causes kinetochore defects: a novel mechanism by which 17-AAG inhibits cell proliferation. Oncogene 25: 4133- 46.